Treatment Strategy With Gene Editing for Late-Onset Retinal Degeneration Caused by a Founder Variant in C1QTNF5.
Li RTH, Roman AJ, Sumaroka A, Stanton CM, Swider M, Garafalo AV, Heon E, Vincent A, Wright AF, Megaw R, Aleman TS, Browning AC, Dhillon B, Cideciyan AV.
Li RTH, et al. Among authors: swider m.
Invest Ophthalmol Vis Sci. 2023 Dec 1;64(15):33. doi: 10.1167/iovs.64.15.33.
Invest Ophthalmol Vis Sci. 2023.
PMID: 38133503
Free PMC article.